Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4689031> ?p ?o }
Showing triples 1 to 70 of
70
with 100 triples per page.
- Q4689031 subject Q7164605.
- Q4689031 subject Q8600594.
- Q4689031 abstract "The Affordable Medicines Facility-malaria (AMFm) is a financing mechanism intended to expand access to affordable and effective antimalarial medication (artemisinin-based combination therapies, ACTs). It works primarily through the commercial private sector, in addition to the public and non-governmental organization sectors which are the more traditional routes for development assistance in malaria control. Its goal is to drive down the price of the most effective malaria medicines so that millions of people can afford to buy them. The program has been called "one of the most important recent advances in fighting malaria" and "a triumph of international cooperation." The AMFm is hosted and managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria in Geneva, Switzerland.The premise of the AMFm is that a factory-gate global subsidy, with measures to support its implementation, will save lives and reduce malaria-related mortality by increasing access to ACTs, and delay the onset of widespread resistance to the artemisinin in ACTs. It includes three elements: (i) price reductions through negotiations with ACT manufacturers, (ii) a buyer subsidy through a 'co-payment' at the top of the global supply chain and (iii) supporting interventions at the country level to promote the appropriate use of ACTs.AMFm Phase 1 was formally launched in April 2009 and began operations in July 2010. AMFm Phase 1 is being implemented through nine pilot programs in eight countries: Cambodia, Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania (mainland and Zanzibar) and Uganda. There are early signs AMFm Phase 1 is effectively increasing availability and decreasing prices of ACTs; however the Global Fund Board will only take a decision on the future of AMFm at the end of 2012 on the basis of an independent evaluation. As part of the Copenhagen Consensus 2012, a panel of leading economists concluded that the AMFm was "one of the best returns on health that could be made globally" and ranked it two of 16 priority solutions to advance global welfare.In November 2012 the Global Fund Board decided to modify the existing AMFm business line by integrating lessons learned from Phase 1 into Global Fund core grant management and financial processes. The AMFm was subsequently renamed the Private Sector Co-payment Mechanism.".
- Q4689031 location Q39.
- Q4689031 location Q71.
- Q4689031 wikiPageExternalLink privatesectorcopayment.
- Q4689031 wikiPageWikiLink Q1019.
- Q4689031 wikiPageWikiLink Q1032.
- Q4689031 wikiPageWikiLink Q1033.
- Q4689031 wikiPageWikiLink Q1036.
- Q4689031 wikiPageWikiLink Q1131025.
- Q4689031 wikiPageWikiLink Q114.
- Q4689031 wikiPageWikiLink Q1151482.
- Q4689031 wikiPageWikiLink Q117.
- Q4689031 wikiPageWikiLink Q12156.
- Q4689031 wikiPageWikiLink Q123452.
- Q4689031 wikiPageWikiLink Q1304270.
- Q4689031 wikiPageWikiLink Q1308239.
- Q4689031 wikiPageWikiLink Q1414657.
- Q4689031 wikiPageWikiLink Q163740.
- Q4689031 wikiPageWikiLink Q1774.
- Q4689031 wikiPageWikiLink Q186517.
- Q4689031 wikiPageWikiLink Q192592.
- Q4689031 wikiPageWikiLink Q193219.
- Q4689031 wikiPageWikiLink Q239569.
- Q4689031 wikiPageWikiLink Q294217.
- Q4689031 wikiPageWikiLink Q311383.
- Q4689031 wikiPageWikiLink Q317749.
- Q4689031 wikiPageWikiLink Q339619.
- Q4689031 wikiPageWikiLink Q39.
- Q4689031 wikiPageWikiLink Q422438.
- Q4689031 wikiPageWikiLink Q424.
- Q4689031 wikiPageWikiLink Q426921.
- Q4689031 wikiPageWikiLink Q4352382.
- Q4689031 wikiPageWikiLink Q507443.
- Q4689031 wikiPageWikiLink Q521616.
- Q4689031 wikiPageWikiLink Q591763.
- Q4689031 wikiPageWikiLink Q6026475.
- Q4689031 wikiPageWikiLink Q655286.
- Q4689031 wikiPageWikiLink Q6741353.
- Q4689031 wikiPageWikiLink Q696265.
- Q4689031 wikiPageWikiLink Q71.
- Q4689031 wikiPageWikiLink Q7164.
- Q4689031 wikiPageWikiLink Q7164605.
- Q4689031 wikiPageWikiLink Q7191.
- Q4689031 wikiPageWikiLink Q7360869.
- Q4689031 wikiPageWikiLink Q7367.
- Q4689031 wikiPageWikiLink Q737498.
- Q4689031 wikiPageWikiLink Q7636174.
- Q4689031 wikiPageWikiLink Q7817.
- Q4689031 wikiPageWikiLink Q7917820.
- Q4689031 wikiPageWikiLink Q79913.
- Q4689031 wikiPageWikiLink Q8600594.
- Q4689031 wikiPageWikiLink Q865909.
- Q4689031 wikiPageWikiLink Q924.
- Q4689031 location "Geneva, Switzerland".
- Q4689031 name "The Affordable Medicines Facility-malaria".
- Q4689031 type Organization.
- Q4689031 type Agent.
- Q4689031 type Non-ProfitOrganisation.
- Q4689031 type Organisation.
- Q4689031 type Agent.
- Q4689031 type SocialPerson.
- Q4689031 type Thing.
- Q4689031 type Q163740.
- Q4689031 type Q43229.
- Q4689031 comment "The Affordable Medicines Facility-malaria (AMFm) is a financing mechanism intended to expand access to affordable and effective antimalarial medication (artemisinin-based combination therapies, ACTs). It works primarily through the commercial private sector, in addition to the public and non-governmental organization sectors which are the more traditional routes for development assistance in malaria control.".
- Q4689031 label "Affordable Medicines Facility-malaria".
- Q4689031 homepage privatesectorcopayment.
- Q4689031 name "The Affordable Medicines Facility-malaria (AMFm)".